Riverhead Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $336K | Buy |
6,436
+500
| +8% | +$26.1K | 0.01% | 902 |
|
|
2019
Q2 | $287K | Buy |
5,936
+100
| +2% | +$4.84K | 0.01% | 979 |
|
|
2019
Q1 | $295K | Hold |
5,836
| – | – | 0.01% | 950 |
|
|
2018
Q4 | $346K | Hold |
5,836
| – | – | 0.02% | 817 |
|
|
2018
Q3 | $384K | Hold |
5,836
| – | – | 0.01% | 893 |
|
|
2018
Q2 | $295K | Hold |
5,836
| – | – | 0.01% | 900 |
|
|
2018
Q1 | $307K | Buy |
5,836
+700
| +14% | +$36.8K | 0.01% | 865 |
|
|
2017
Q4 | $239K | Buy |
5,136
+900
| +21% | +$41.9K | 0.01% | 986 |
|
|
2017
Q3 | $171K | Buy |
4,236
+1,194
| +39% | +$48.2K | 0.01% | 1053 |
|
|
2017
Q2 | $103K | Buy |
3,042
+1,542
| +103% | +$52.2K | 0.01% | 1208 |
|
|
2017
Q1 | $44K | Sell |
1,500
-1,400
| -48% | -$41.1K | ﹤0.01% | 1297 |
|
|
2016
Q4 | $95K | Hold |
2,900
| – | – | 0.01% | 986 |
|
|
2016
Q3 | $91K | Sell |
2,900
-400
| -12% | -$12.6K | 0.01% | 945 |
|
|
2016
Q2 | $140K | Sell |
3,300
-4,540
| -58% | -$193K | ﹤0.01% | 1041 |
|
|
2016
Q1 | $285K | Sell |
7,840
-160
| -2% | -$5.82K | ﹤0.01% | 1139 |
|
|
2015
Q4 | $320K | Buy |
+8,000
| New | +$320K | ﹤0.01% | 1115 |
|